In Illinois you will pretty much have to demand

that the doctor do a test for Lyme and co-infection.

Flawed Testing

The ELISA test is set too high for anyone to be positive.

The Western Blot test leaves out BAND N31 and BAND N34 SO SPECIFIC for LYME;

They did this at the Second National Conference on Serologic Diagnosis of Lyme Disease, October 27-29.

1994 YALE University/Smith-Kline made the LYMErix© vaccine out of it.

To Read about it - Click here!

The vaccine gave people LYME!

 With thousands of adverse events they had to take it off the market. They told the press; THERE WAS A LACK OF INTEREST IN THE VACCINE....Don't you think if it worked, us SICK people would WANT a CURE???

 "Lack of Interest" indeed.

  The Physician's Guide to Laboratory Test Selection and Interpretation - ARUP Lab, Inc. Utah

Borrelia burgdorferi - Lyme Disease

• Clinical Background
• Tests
• References
• Algorithm

 Lyme Disease Testing Algorithm

Lyme disease is the most common vector-borne disease in the U.S.

Epidemiology

• Gender – M:F; 1:1 except for the presentation of acrodermatitis chronica atrophicans (M<F)
• Transmission – infected Ixodes tick

Organism

• Borrelia burgdorferi
• Member of the Spirochaetales family which also includes Treponema and Leptospira

Risk Factors

• Exposure in regions where deer population is high during the spring or summer
• Northeast or Midwest geographic location

Clinical Presentation

• Centers for Disease Control (CDC) clinical case epidemiologic surveillance criteria for defining Lyme disease
  • Erythema migrans (EM) ≥5 cm in diameter or
  • Laboratory confirmation of infection and at least 1 late manifestation
    • Musculoskeletal manifestation – recurrent, brief attacks of objective joint swelling in 1 or more joints
    • Neurological manifestations
      • Lymphocytic meningitis
      • Cranial neuritis
      • Radiculoneuropathy
      • Encephalomyelitis – requires demonstration of CSF antibody production
      • Cardiovascular manifestations – acute second or third degree arteriovenous (AV) heart block
• Lyme disease stages
  • Stage 1 early localized
    • May begin within hours to several weeks after infection
    • Characterized by erythema migrans (EM) or lymphocytoma (rare in U.S.)
    • Regional adenopathy and/or minor constitutional symptoms
  • Stage 2 early disseminated
    • Occurs weeks to months following the tick bite
    • Characterized by neurologic and cardiac involvement (manifested in 15% and 8% of patients, respectively)
    • Manifestations
      • Fever
      • Myalgias
      • Multiple EM lesions
      • Meningitis
      • Bells Palsy
      • Guillain-Barré-like syndrome
      • Cardiac conduction abnormalities
      • Arthritis
  • Stage 3 late disseminated
    • Can develop within a few weeks to 2 years following infection
    • Symptoms are more severe than early disseminated
    • Characterized by arthritis
      • Occurs in 60% of individuals not effectively treated early in infection
      • Tends to be intermittent, lasting from several days to weeks
    • Late Lyme disease can affect central nervous system
    • Patients may have memory loss, fatigue and polyneuropathy
• Initial symptoms usually appear in late spring/early summer, when ticks are active
• Late manifestations occur anytime

Diagnosis           <REMEMBER Lyme is a Clinical Diagnosis!

• Laboratory testing
  • Diagnosis depends on clinical features, combined with available laboratory tests
    • C6 peptide antibodies or Borrelia antibodies by ELISA
  • Refer to the Lyme Disease Testing algorithm
• Current CDC recommendations for serologic diagnosis of Lyme disease
  • Screen with a polyvalent ELISA test
  • Confirm equivocal and positive results with Western Blot
  • Refer to Lyme Disease Testing algorithm
• Co- and triple-infections by parasites that cause babesiosis and human granulocytic ehrlichiosis may occur
  • Serologic testing specific for these agents is recommended
  • Co- and triple-infections by parasites that cause babesiosis and human granulocytic ehrlichiosis may occur; serological testing specific for these agents is recommended

Treatment

• Lyme disease, caught early, is easily treated
  • Treatment prevents progression to chronic stage <The standard was changed at the Dearborn Conference NOT to find Lyme early!
  • Severe, long-term effects occur in <10% of untreated patients < yeah right!
• If known tick bite and erythema migrans present, proceed with treatment; testing is not necessary < not everyone gets a rash!

 

 

I knew, i had this terrible disease....i had tons of symptoms, and i knew i was real sick.

This is what i discovered:

 

The reason people flock to IgeneX

Dr. Nick Harris was at the Dearborn Conference in 1994

DID NOT CHANGE HIS LAB criteria for Lyme.

He Left the testing the same as it was before they revised testing at the conference.

Read here: IgeneX Lab - Nick Harris Explains Testing

This document has been removed from the above site (IgeneX) so we we kept a backup for you.

An Understanding of Laboratory Testing by Nick Harris, MD

;o)